171 related articles for article (PubMed ID: 20222179)
21. Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma.
Sarkozy C; Seymour JF; Ferme C; Caballero D; Ghesquieres H; Leppa S; Delarue R; Pedersen LM; Mounier C; Gomes Da Silva M; Chassagne-Clement C; Maerevoet M; Salles G
Blood; 2014 Apr; 123(17):2740-2. PubMed ID: 24764560
[No Abstract] [Full Text] [Related]
22. Successful treatment of isolated cutaneous relapse of follicular lymphoma with rituximab.
Ferrer A; López-Guillermo A; Montoto S; Estrach T; Colomo L; Montserrat E
Ann Hematol; 2001 Aug; 80(8):479-81. PubMed ID: 11563595
[TBL] [Abstract][Full Text] [Related]
23. AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients.
Grillo-López AJ
Expert Rev Anticancer Ther; 2002 Jun; 2(3):323-9. PubMed ID: 12113055
[TBL] [Abstract][Full Text] [Related]
24. Principles of maintenance therapy.
Berinstein NL
Leuk Res; 2006 Mar; 30 Suppl 1():S3-10. PubMed ID: 16750676
[TBL] [Abstract][Full Text] [Related]
25. Rituximab and statins.
Carver JR; Johnson T; Schuster SJ
J Clin Oncol; 2010 Oct; 28(30):e611; author reply e612. PubMed ID: 20805449
[No Abstract] [Full Text] [Related]
26. Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
Landgren O; Dunleavy K; Wilson WH
J Natl Cancer Inst; 2009 Sep; 101(18):1287-8; author reply 1289-90. PubMed ID: 19687413
[No Abstract] [Full Text] [Related]
27. Current status of rituximab maintenance therapy.
Vose JM
Clin Adv Hematol Oncol; 2007 Dec; 5(12):968-9,1006. PubMed ID: 18277958
[No Abstract] [Full Text] [Related]
28. Minimal residual disease (MRD) in follicular lymphoma in the era of immunotherapy with rituximab.
Hirt C; Schüler F; Dölken G
Semin Cancer Biol; 2003 Jun; 13(3):223-31. PubMed ID: 12959353
[TBL] [Abstract][Full Text] [Related]
29. Follicular lymphoma, survival, and rituximab: is it time to declare victory?
Horning SJ
J Clin Oncol; 2008 Oct; 26(28):4537-8. PubMed ID: 18662966
[No Abstract] [Full Text] [Related]
30. Rituximab maintenance therapy: a step forward in follicular lymphoma.
van Oers MH
Haematologica; 2007 Jun; 92(6):826-33. PubMed ID: 17550856
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibition as a mechanism for the therapeutic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors) in follicular lymphoma.
Barker CA; Yahalom J
J Clin Oncol; 2010 Aug; 28(24):e426; author reply e427-8. PubMed ID: 20566995
[No Abstract] [Full Text] [Related]
32. Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab.
Aoi J; Makino K; Sakai K; Masuguchi S; Fukushima S; Jinnin M; Inoue Y; Koga H; Hashimoto T; Ihn H
J Dermatol; 2013 Apr; 40(4):285-6. PubMed ID: 23398274
[No Abstract] [Full Text] [Related]
33. Treatment approaches to asymptomatic follicular lymphoma.
Sarkozy C; Salles G
Expert Rev Hematol; 2013 Dec; 6(6):747-58. PubMed ID: 24219551
[TBL] [Abstract][Full Text] [Related]
34. Haematological cancer: rituximab maintenance improves the outcome of elderly patients with FL.
Jones B
Nat Rev Clin Oncol; 2013 Nov; 10(11):607. PubMed ID: 23999211
[No Abstract] [Full Text] [Related]
35. Prolonged remission in a patient with relapsed follicular lymphoma after a single course of rituximab.
Jensen M; Elter T; Engert A; Reiser M
Onkologie; 2006 Mar; 29(3):90-2. PubMed ID: 16514269
[TBL] [Abstract][Full Text] [Related]
36. Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma.
Yang SH; Kuo SH
Ann Hematol; 2008 Apr; 87(4):325-7. PubMed ID: 17932671
[No Abstract] [Full Text] [Related]
37. Factors predictive for response of follicular and mantle-cell lymphoma to rituximab.
Pfreundschuh M
Nat Clin Pract Oncol; 2006 Apr; 3(4):184-5. PubMed ID: 16596141
[No Abstract] [Full Text] [Related]
38. Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden.
Kasteng F; Erlanson M; Hagberg H; Kimby E; Relander T; Lundkvist J
Acta Oncol; 2008; 47(6):1029-36. PubMed ID: 18607857
[TBL] [Abstract][Full Text] [Related]
39. Rituximab maintenance in follicular lymphoma: PRIMA.
Friedberg JW
Lancet; 2011 Jan; 377(9759):4-6. PubMed ID: 21176951
[No Abstract] [Full Text] [Related]
40. [Rituximab cost analysis for maintenance treatment of patients with follicular lymphoma].
Grupo de Farmacoeconomía del Linfoma Folicular
Farm Hosp; 2008; 32(1):25-34. PubMed ID: 18426699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
